Position in NVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$213,850
-$172,186 QoQ
Shares Held
1,400
-50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOWEN HANES & CO INC holds $152,182,717 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
114,646 | $137,509,863 | |
| 2 | JNJ |
Johnson & Johnson
|
36,439 | $9,254,412 | |
| 3 | ABBV |
AbbVie Inc.
|
12,440 | $3,130,401 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,445 | $947,560 | |
| 5 | PFE |
Pfizer Inc
|
35,984 | $866,494 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,204 | $283,214 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,510 | $190,773 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $213,850 | 1,400 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $386,036 | 2,800 | Shares | Sole | 2026-02-10 | |
| 2021-12-31 | $415,045 | 4,745 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $388,046 | 4,745 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $432,933 | 4,745 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $405,602 | 4,745 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $448,070 | 4,745 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $711,332 | 8,180 | Shares | Sole | 2021-02-08 | |
| 2020-06-30 | $812,698 | 9,305 | Shares | Sole | 2021-02-08 | |
| 2020-03-31 | $832,415 | 10,096 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||